Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system (Q24317105)

myeloid dendritic cell differentiation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Peter-Michael Kloetzel

6

object named as

Peter-Michael Kloetzel

0 references

author name string

Frédéric Ebstein

1

0 references

Nicole Lange

2

0 references

Sabrina Urban

3

0 references

Ulrike Seifert

4

0 references

Elke Krüger

International Journal of Biochemistry & Cell Biology

5

0 references

language of work or name

English

0 references

publication date

May 2009

0 references

published in

0 references

volume

41

0 references

page(s)

1205-15

0 references

issue

5

0 references

cites work

Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Involvement of proteasomes in gene induction by interferon and double-stranded RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

The complex route to MHC class I-peptide complexes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

E1-L2 activates both ubiquitin and FAT10

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Protein degradation and the generation of MHC class I-presented peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Dendritic cells as vectors for therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Drug discovery in the ubiquitin regulatory pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Taking dendritic cells into medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Immunity by ubiquitylation: a reversible process of modification

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

UBP43 (USP18) specifically removes ISG15 from conjugated proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Activation of human dendritic cells through CD40 cross-linking.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

The seven dirty little secrets of major histocompatibility complex class I antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Proteasome-independent functions of ubiquitin in endocytosis and signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

FAT10, a ubiquitin-independent signal for proteasomal degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN- / on antigen cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021

Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOCEL.2008.10.023

7 January 2021